@article {262, title = {National Mass Gathering Pharmaceutical Care Program at Healthcare Institution in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {9}, year = {2020}, month = {February 2020}, pages = {1-4}, type = {Review Article}, chapter = {1}, abstract = {

Objective: To explore the pharmaceutical care services during mass gathering (MG) Hajj at the healthcare organizations in Saudi Arabia (SA). Methods: It is a descriptive analysis of a newly established program at the MOH in SA called MG pharmaceutical care program during Hajj and Umra Seasons, which was analyzed within the Pharmacy Strategic Plan 2012-2020 and update the plan with new Saudi vision 2030. Results: MG pharmaceutical care program is a new program established by the healthcare organizations in the last four years, which amongst to provide pharmaceutical care services in various fields. Conclusion: The mass gathering of pharmaceutical care services is a new initiative, part of the mass gathering medicine. The program should expand after the foundation stage with performance indication monitoring and follow up. Further assessment of the new project is required to validate the clinical and economic outcomes to research the high level of quality and professionalism in the future.

}, keywords = {Healthcare, Institution, Mass Gathering, National, Pharmaceutical Care, Saudi Arabia}, doi = {10.5530/ijpcs.2020.9.1}, author = {Yousef Ahmed Alomi and Nouf Hameed AL-Muwallad and Nezar Adnan Yahya Khayat and Yasir Abdulraheem Bamagaus and Taha Mohamd Rafuden Bakhsh and Nojoud Adnan Khayat and Ahmad M. AlKharoby and Wael H. Motair} } @article {220, title = {National Antidote of Poisoning Distribution System: New Initiatives in Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {8}, year = {2019}, month = {September 2019}, pages = {141-155}, type = {Review Article }, chapter = {141}, abstract = {

Objective: To declare the national antidote of poisoning distribution system as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project, the national antidote of poisoning distribution system. The project drove the antidote of poisoning distribution guidelines and the international business model, pharmacy project guidelines project management institution guidelines of a new project. The initiative project is written through project management professionals and consisted of several parts, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The antidote of poisoning distribution system with a defined vision, mission and goals was initiated. The services had various advantages with clinical and economic impacts on patients and healthcare services as illustrated in the review. The extension of the project was assured by risk management elements description. Furthermore, the monitoring and controlling of the services was demonstrated. The conversion to operation project though closing project stage was revealed in the analysis. Conclusion: The national antidote of poisoning distribution system is new initiative project and is considered as a part of the management of poisoning. There are multiple locations of antidote distribution services suggested and it is highly required in the Kingdom of Saudi Arabia.

}, keywords = {Antidote, Distribution, National, Poisoning, Saudi Arabia, System}, doi = {10.5530/ijpcs.2019.8.24}, author = {Yousef Ahmed Alomi and Amal Hassan Al-Najjar and Saeed Jamaan Alghamdi and Radi Abdullah Alattyh} } @article {215, title = {National Survey of Pharmacy and Therapeutic Committees in Saudi Arabia: Scope, Structure and Responsibilities}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {8}, year = {2019}, month = {December 2019}, pages = {222-226}, type = {Research Article}, chapter = {222}, abstract = {

Objectives: The Pharmacy and Therapeutics (PTC) committee, sometimes aptly named the Formulary Committee. PTC is charged with determining the hospital formulary, decisions are made about the inclusion or exclusion of new pharmacotherapeutic and diagnostic agents for inpatients and outpatients. This committee is typically composed of a multidisciplinary team of pharmacy, physician, nursing and hospital clinical and administrative leadership. The aim of the study was to explore the Therapeutic Committee at MOH hospitals in Saudi Arabia: scope, structure and responsibilities. Methods: It is a 4-month cross-sectional survey of National Survey of Pharmacy and Therapeutic Committee at MOH hospitals in Saudi Arabia. The survey consisted of 93 questions divided in two parts: the first part collects the demographic information, the second part contains questions on 4 domains: (1) scope, structure and responsibilities, that is including questions about the pharmacy and therapeutic committee membership, clear mission, vision and values of the pharmacy and therapeutic committee, the responsibilities of the PTC committee and the Sub-committees of Pharmacy and Therapeutic Committee, (2) formulary management system, (3) evaluation of drug formulary and decision-making, (4) committee meetings organization and management. The survey was distributed to the fifty-drug information centers at Ministry of Health hospitals. The survey was in an electronic format with analyzed scope, structure and responsibilities through the survey monkey system. Results: The total number responders were fifty drug information centers. Of those, 48 (96\%) was Saudi and 2 (4\%) was non-Saudi. There were 16 (32\%) females and 34 (68\%) were males. Most of the PTC committee members consisted of a chief of pharmacy department 45 (90\%), medical director 41 (82\%), physician medical 40 (80\%) and head of drug information center 32 (64\%). The highest score statements related to committee were the functions of PTC (3.78), objectives (3.61), mission (3.57), with least one was a vision (3.56) and values (3.5). The most responsibility scoring statement was distributed the addition and deletion (4.08), all the departments receive the copy of the revised formulary (4.04), drug evaluation and selection for the hospital was (3.9), drug policy development was (3.9), while the lowest scores were Holds educational programs within the hospital (3.25) and drug monitoring system was (3.57). Most of the subcommittee existed antibiotic committee 38 (76\%), medication safety committee 38 (76\%), followed by drug utilization committee 9 (18\%) and therapeutic guidelines committee 9 (18\%). Conclusion: One-third of hospital missed drug information center pharmacist as the member of PTC committee and the pharmacy qualifications of committee members need to improve. Update the committee system and close monitoring required for all MOH hospitals in Saudi Arabia.

}, keywords = {Ministry of Health, National, Responsibilities, Saudi Arabia, Scope, Structure}, doi = {10.5530/ijpcs.2019.8.49}, author = {Yousef Ahmed Alomi and Sultan Mohammed Al-Jarallah and Rasha Abdelsalam Elshenawy and Faiz A Bahadig Rph} }